* IDEAYA Biosciences Inc IDYA.OQ reported a quarterly
adjusted
loss of $1.49 per share for the quarter ended December 31,
lower than the same quarter last year, when the company reported
EPS of -52 cents. The mean expectation of thirteen analysts for
the quarter was for a loss of 64 cents per share. Wall Street
expected results to range from -73 cents to -41 cents per share.
* Revenue rose 78.4% to $7.00 million from a year ago;
analysts
expected $4.67 million.
* IDEAYA Biosciences Inc's reported EPS for the quarter was
a loss
of $1.49.
* The company reported a quarterly loss of $130.31 million.
* IDEAYA Biosciences Inc shares had fallen by 18.3% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for IDEAYA
Biosciences Inc is $52.00
This summary was machine generated from LSEG data February 18 at
02:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.64 -1.49 Missed
Sep. 30 2024 -0.63 -0.60 Beat
Jun. 30 2024 -0.54 -0.68 Missed
Mar. 31 2024 -0.51 -0.53 Missed